Director, HEOR Strategy - Aesthetics

Company Description

AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on X, Facebook, Instagram, YouTube, LinkedIn and Tik Tok.

Job Description

Purpose:

AbbVie seeks a Director for the Aesthetics & Regenerative Medicine HEOR-Strategy team to lead strategic research for pipeline and on-market products, supporting approval, reimbursement, and differentiation. AbbVie has a robust Aesthetics & Regenerative Medicine portfolio with over 30 products in the pipeline, including both cash-pay and reimbursed drugs and devices. The role requires expertise in patient-centered outcomes research, HEOR strategy, and regulatory submissions, with responsibilities spanning both cash-pay and reimbursed portfolios. The Director may manage 1-2 direct reports.

Responsibilities:

1. Lead patient centered outcomes research (PCOR) and collaborate with the clinical development organization on co-primary and secondary PRO endpoints required for approval globally
2. Lead PRO strategy, PRO development/implementation, and global regulatory submissions to enable approvals for drugs and devices
3. Develop and execute HEOR strategic plans, including real-world evidence studies, economic modeling, and payer dossier to support product approval, market access, reimbursement, and differentiation
4. Develop strategic plans and budgets in collaboration with cross-functional stakeholders, ensuring alignment with portfolio priorities
5. Build strong partnerships with HEOR Centers of Excellence (COEs) to maintain a unified cross-functional HEOR presence
6. Lead HEOR projects design, execution, and scientific communication of findings at congresses and